BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2145583)

  • 1. Cancer chronotherapy: a drug delivery challenge.
    Hrushesky WJ
    Prog Clin Biol Res; 1990; 341A():1-10. PubMed ID: 2145583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical cancer chronotherapy trials: a review.
    Bjarnason GA
    J Infus Chemother; 1995; 5(1):31-7. PubMed ID: 7634175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
    Lévi F; Focan C; Karaboué A; de la Valette V; Focan-Henrard D; Baron B; Kreutz F; Giacchetti S
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1015-35. PubMed ID: 17692427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronomodulated 5-day infusion of floxuridine and L-folinic acid in patients with advanced malignancies: a feasibility and tolerability study.
    Garufi C; Lévi F; Giunta S; Aschelter A; Pace R; Nisticò C; Terzoli E
    J Infus Chemother; 1995; 5(3 Suppl 1):134-7. PubMed ID: 8528973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronopharmacology and chronotherapy of cancers].
    Lévi F
    Pathol Biol (Paris); 1996 Sep; 44(7):631-44. PubMed ID: 8977920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian pattern of continuous FUDR infusion reduces toxicities.
    Roemeling RV; Hrushesky WJ
    Prog Clin Biol Res; 1987; 227B():357-73. PubMed ID: 2957701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer chronotherapy: is there a right time in the day to treat?
    Hrushesky WJ
    J Infus Chemother; 1995; 5(1):38-43. PubMed ID: 7634176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The circadian-timing system: a determinant of drug activity and a target of anticancer treatments].
    Lévi F
    Ann Pharm Fr; 2008 Jun; 66(3):175-84. PubMed ID: 18706346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronotherapy of colorectal cancer metastases.
    Lévi F; Giacchetti S; Zidani R; Brezault-Bonnet C; Tigaud JM; Goldwasser F; Misset JL
    Hepatogastroenterology; 2001; 48(38):320-2. PubMed ID: 11379299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronotherapeutics: the relevance of timing in cancer therapy.
    Lévi F
    Cancer Causes Control; 2006 May; 17(4):611-21. PubMed ID: 16596317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian-based infusional FUDR therapy.
    Lanning RM; von Roemeling R; Hrushesky WJ
    Oncol Nurs Forum; 1990; 17(1):49-56. PubMed ID: 2137216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian chemotherapy for gynecological and genitourinary cancers.
    Kobayashi M; Wood PA; Hrushesky WJ
    Chronobiol Int; 2002 Jan; 19(1):237-51. PubMed ID: 11962679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cell cycle automaton model for probing circadian patterns of anticancer drug delivery.
    Altinok A; Lévi F; Goldbeter A
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1036-53. PubMed ID: 17692993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological perspectives on circadian cancer therapy.
    Wood PA; Hrushesky WJ
    J Infus Chemother; 1995; 5(4):182-90. PubMed ID: 8934723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formal clinical evaluation of the CADD-Micro system for circadian delivery of FUDR in patients with metastatic renal cell cancer.
    Bjarnason GA; Doyle N; Sone M; Beattie K; Elia J; Owens B
    J Infus Chemother; 1995; 5(2):82-8. PubMed ID: 8521240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronobiology and cancer].
    Lévi F
    Pathol Biol (Paris); 1987 Jun; 35(6):960-8. PubMed ID: 3306577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronotherapy of cancer: biological basis and clinical application.
    Lévi F
    Pathol Biol (Paris); 1994 Apr; 42(4):338-41. PubMed ID: 7808787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronotherapy and the molecular clock: Clinical implications in oncology.
    Innominato PF; Lévi FA; Bjarnason GA
    Adv Drug Deliv Rev; 2010 Jul; 62(9-10):979-1001. PubMed ID: 20600409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of the chronotherapeutic index in the experimental animal laboratory.
    Halberg E; Cornélissen G; Halberg F
    In Vivo; 1992; 6(4):371-85. PubMed ID: 1520840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.